Advent announced its acquisition of Suven Pharma in December. Including the cost of the open offer, the deal size would go up to Rs 9,589 crore. The deal was given a green light by the union cabinet on September 14. A Suven Pharma-Cohance combination could bring together the strong client base of the former, which is a drug development partner to large global pharmaceutical companies.